GENinCode (LON:GENI) Sets New 1-Year Low – What’s Next?

by · The Cerbat Gem

GENinCode Plc (LON:GENI – Get Free Report) shares hit a new 52-week low during trading on Thursday . The stock traded as low as GBX 3 ($0.04) and last traded at GBX 3.10 ($0.04), with a volume of 629877 shares. The stock had previously closed at GBX 3.15 ($0.04).

GENinCode Stock Down 1.6 %

The company has a debt-to-equity ratio of 9.28, a quick ratio of 15.89 and a current ratio of 2.60. The firm has a market capitalization of £5.50 million, a P/E ratio of -0.90 and a beta of 0.66. The stock has a fifty day moving average price of GBX 3.71 and a two-hundred day moving average price of GBX 4.40.

GENinCode Company Profile

(Get Free Report)

GENinCode Plc is a UK based company specialising in genetic risk assessment of cardiovascular disease. Cardiovascular disease is the leading cause of death and disability worldwide.

GENinCode operates business units in the UK, in the United States through GENinCode U.S. Inc and in Europe through GENinCode S.L.U.

GENinCode predictive technology provides patients and physicians with globally leading preventative care and treatment strategies.

Featured Articles